BYAH

Park Ha Biological Technology Co., Ltd.
CAPPED RATING

Park Ha Biological Technology Co., Ltd. (BYAH) is rated C- (2.1/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Profitability (B); its weakest is Momentum (F).

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
C-
Factor Score 2.0 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
B
Factor Score 3.4 / 5.0
Momentum
F
Factor Score 0.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA 0.9
Rev Growth YoY 1.5%
Gross Margin 94.9%
Price Return 3M -49.5%
Price Return 12M -98.6%
Catalyst Signal 0.00
Market Cap $28.9M
TTM Revenue $2.5M
Price / Sales 11.4
ROE -113.0%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C- (2.0) C- (2.1) B (3.4) F (0.4) C+ (2.6) C- (2.1)
2026-11-10 D+ (1.7) C- (2.1) B (3.4) D- (0.7) C+ (2.6) C- (2.1)
2026-11-03 D+ (1.7) C (2.2) B (3.4) D- (1.0) C+ (2.6) C (2.2)
2026-10-27 D+ (1.7) C- (2.1) B (3.4) D (1.2) C (2.4) C (2.2)
2026-10-20 D+ (1.7) C- (2.1) B (3.4) F (0.4) C (2.3) C- (2.0)
Page 1 of 4